PFO
MDWD icon

Pathstone Family Office’s MediWound MDWD Stock Holding History

Pathstone Family Office’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,857
Closed -$27.9K – 1551
2022
Q3 		$27.9K Buy
2,857
+1,428
+100% +$18K ﹤0.01% 1458
2022
Q2 		$18.4K Hold
1,429
– – ﹤0.01% 1035
2022
Q1 		$20K Buy
+1,429
New +$23.2K ﹤0.01% 952

Other funds holding MDWD

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Pathstone Family Office's MDWD Position: Q4 2022 in Review

Pathstone Family Office sold out of MediWound (MDWD) in Q4 2022, closing a stake of 2,857 shares — an estimated $27.9K sold.

Pathstone Family Office first reported a position in MDWD in Q1 2022 and held it in 3 quarters. The position peaked at $27.9K in Q3 2022. 19 funds tracked by Wall St. Rank hold MDWD as of Q4 2022.

  • Pathstone Family Office reported no remaining MediWound position as of Q4 2022 after selling out during the quarter.
  • Pathstone Family Office sold 2,857 MediWound shares in Q4 2022, an estimated $27.9K.
  • Pathstone Family Office first reported a position in MediWound in Q1 2022 and held it in 3 quarters.
  • Pathstone Family Office's MediWound position peaked at $27.9K in Q3 2022.
  • 19 funds tracked by Wall St. Rank held MediWound as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.